RxDoctor Payments Data

Polina Dasgupta

Medical · Miami, FLNPI 1174037477

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (54.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Boehringer Ingelheim accounts for 74.0% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2024 at $12,455 and has fallen 99.7% since, to $41 in 2025. Among medical clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$17,146in general payments, 2019–2025

Across 170 payments — averaging $100.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$13K
  • AbbVie$1K
  • Supernus Pharmaceuticals, Inc.$863
  • Idorsia Pharmaceuticals US Inc$506
  • Johnson & Johnson$443
  • Corium, LLC$404
  • plus $1K from 8 others

What the payments were for

  • Consulting fees$9,30054%
  • Travel & lodging$2,92817%
  • Food & beverage$4,91829%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,146 in reported general payments places this provider in the 95th percentile of 2,031 medical providers in Florida.

See all medical providers in Florida

Other medical in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →